Targeting Rho kinase to restore endothelial barrier function following vascular scaffold implantation

Belay Tesfamariam1

  • 1Division of Pharmacology and Toxicology, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), 10903 New Hampshire Ave, Bldg. 22, Rm. 4178, Silver Spring, MD 20993, USA.